Akram M ElKashlan (Akram M Elkashlan)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Venous Thromboembolism

Magnetic Resonance

Top Venues

Clinical and translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Majdoleen Al Alawneh, Ahmed Awaisu, Ibtihal Abdallah, Hazem F Elewa, Mohammed Ibn-Mas'ud Danjuma, Kamal M Matar, Akram M ElKashlan, Yasser Elshayep, Fathy Ibrahim, Ousama Rachid
Pharmacokinetics of single-dose rivaroxaban under fed state in obese vs. non-obese subjects: An open-label controlled clinical trial (RIVOBESE-PK). Clinical and translational science 17 (6) (2024)
Majdoleen Al Alawneh, Ahmed Awaisu, Ibtihal Abdallah, Hazem F Elewa, Mohammed Ibn-Mas'ud Danjuma, Kamal M Matar, Akram M ElKashlan, Yasser Elshayep, Fathy Ibrahim, Ousama Rachid
Pharmacokinetics of single-dose rivaroxaban under fed state in obese vs. non-obese subjects: An open-label controlled clinical trial (RIVOBESE-PK). Clinical and translational science 17 (6) (2024)
Majdoleen Al Alawneh, Ahmed Awaisu, Ibtihal Abdallah, Hazem F Elewa, Mohammed Ibn-Mas'ud Danjuma, Kamal M Matar, Akram M ElKashlan, Yasser Elshayep, Fathy Ibrahim, Ousama Rachid
Pharmacokinetics of single-dose rivaroxaban under fed state in obese vs. non-obese subjects: An open-label controlled clinical trial (RIVOBESE-PK). Clinical and translational science 17 (6) (2024)
Mohamed Hamdi, Akram M ElKashlan, Mohamed A Hammad, Isra H Ali
SARS-CoV-2 Papain-like Protease Responsive ZnO/Daclatasvir-Loaded Chitosan/Gelatin Nanofibers as Smart Antimicrobial Medical Textiles: In Silico, In Vitro and Cell Studies. Pharmaceutics 15 (8) (2023)